Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05668988 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Dizal Pharmaceuticals |
| Last Updated on CT.gov | February 17, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT05668988 is currently active_not_recruiting participants. This clinical trial study for non-small cell lung cancer is not currently accepting new participants at 15 locations across the United States. The study is sponsored by Dizal Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05668988 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05668988 was last updated 1 week ago (February 17, 2026). HelloStudys verifies this status automatically.